Interaction of Saccharomyces boulardii with intestinal brush border membranes: key to probiotic effects?
- PMID: 20706146
- DOI: 10.1097/MPG.0b013e3181e23271
Interaction of Saccharomyces boulardii with intestinal brush border membranes: key to probiotic effects?
Abstract
The probiotic Saccharomyces boulardii exerts beneficial effects in humans, which include trophic effects, anti-inflammatory effects, antisecretory effects, inhibition of toxins, immunostimulatory effects, and resistance to bacterial overgrowth. This short communication discusses the interactions of the probiotic with brush border membrane (BBM) constituents because most of these effects are BBM mediated. The use of bacterial and yeast probiotics has increased dramatically in more and more clinical states, but their exact mechanisms of action remain largely unknown. The present communication focuses on the interactions of a confirmed yeast probiotic (S boulardii) on the constituents of BBMs.
Similar articles
-
Review article: yeast as probiotics -- Saccharomyces boulardii.Aliment Pharmacol Ther. 2007 Sep 15;26(6):767-78. doi: 10.1111/j.1365-2036.2007.03442.x. Aliment Pharmacol Ther. 2007. PMID: 17767461
-
Effects of Saccharomyces boulardii on intestinal mucosa.Dig Dis Sci. 2006 Aug;51(8):1485-92. doi: 10.1007/s10620-005-9016-x. Epub 2006 Jul 13. Dig Dis Sci. 2006. PMID: 16838119 Review.
-
Saccharomyces boulardii ameliorates Citrobacter rodentium-induced colitis through actions on bacterial virulence factors.Am J Physiol Gastrointest Liver Physiol. 2008 Jan;294(1):G295-306. doi: 10.1152/ajpgi.00173.2007. Epub 2007 Nov 21. Am J Physiol Gastrointest Liver Physiol. 2008. PMID: 18032474
-
Saccharomyces boulardii produces a soluble anti-inflammatory factor that inhibits NF-kappaB-mediated IL-8 gene expression.Biochem Biophys Res Commun. 2006 Apr 28;343(1):69-76. doi: 10.1016/j.bbrc.2006.02.080. Epub 2006 Feb 23. Biochem Biophys Res Commun. 2006. PMID: 16529714
-
Saccharomyces boulardii in childhood.Eur J Pediatr. 2009 Mar;168(3):253-65. doi: 10.1007/s00431-008-0879-7. Epub 2008 Dec 19. Eur J Pediatr. 2009. PMID: 19096876 Review.
Cited by
-
Probiotics, enteric and diarrheal diseases, and global health.Gastroenterology. 2011 Jan;140(1):8-14. doi: 10.1053/j.gastro.2010.11.010. Epub 2010 Nov 12. Gastroenterology. 2011. PMID: 21075108 Free PMC article. Review. No abstract available.
-
Saccharomyces boulardii and bismuth subsalicylate as low-cost interventions to reduce the duration and severity of cholera.Pathog Glob Health. 2015 Sep;109(6):275-82. doi: 10.1179/2047773215Y.0000000028. Epub 2015 Aug 11. Pathog Glob Health. 2015. PMID: 26260354 Free PMC article. Clinical Trial.
-
Saccharomyces boulardii CNCM I-745 Improves Intestinal Enzyme Function: A Trophic Effects Review.Clin Med Insights Gastroenterol. 2018 Feb 9;11:1179552217752679. doi: 10.1177/1179552217752679. eCollection 2018. Clin Med Insights Gastroenterol. 2018. PMID: 29449779 Free PMC article. Review.
-
Influence of Saccharomyces boulardii CNCM I-745on the gut-associated immune system.Clin Exp Gastroenterol. 2016 Sep 13;9:269-279. doi: 10.2147/CEG.S111003. eCollection 2016. Clin Exp Gastroenterol. 2016. PMID: 27695355 Free PMC article. Review.
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources